GLP-1 Drugs are transforming diabetes treatment and obesity treatment by delivering clinically proven improvements in glycaemic control and weight management

Agentic AI and Autonomous DMTA Loops transform how industries approach innovation, experimentation, and product development across sectors

The pharmaceutical industry has undergone a fundamental shift from traditional drug discovery methods then characterized by long timelines, high costs, and high failure rates

Drug development fundamentally depends on identifying the right biological target, a target typically a gene, protein, or pathway acts as the intervention point for therapy.

Most office jobs today involve sitting for eight hours or more. Screens have replaced walking, and meetings have replaced movement.

Artificial intelligence (AI) is transforming every stage of the pharmaceutical value chain, from identifying disease targets to optimizing clinical trials and commercializing innovative therapies